INBX · Inhibrx Biosciences Inc. Common Stock
View on chartInsiders & Stakes
| Inhibrx, Inc. | ▼ Sell | Other | 1,157,926 Shares held | 5/29/2024 | View profile |
| Mark Lappe Chief Executive Officer | ▲ Buy | Open Market | 705,548 Shares held | 9/16/2024 | View profile |
| Jon Faiz Kayyem Director | ▼ Sell | Gift | 419,360 Shares held | 3/27/2025 | View profile |
| Douglas Forsyth Director | ▲ Buy | Open Market | 224,564 Shares held | 8/23/2024 | View profile |
| VIKING GLOBAL INVESTORS LP 10% Owner | ▼ Sell | Open Market | 102,864 Shares held | 10/7/2025 | View profile |
| Brendan P. Eckelman Chief Scientific Officer | ▲ Buy | Grant | 40,000 Shares held | 5/29/2024 | View profile |
| Kristiina Vuori, MD Director | ▲ Buy | Open Market | 20,443 Shares held | 10/3/2024 | View profile |
| Kimberly Manhard Director | ▲ Buy | Open Market | 10,000 Shares held | 8/28/2024 | View profile |
Transaction History
| VIKING GLOBAL INVESTORS LP | ▼ Sell | Open Market | 16,315 | $526K | 10/7/2025 |
| VIKING GLOBAL INVESTORS LP | ▼ Sell | Open Market | 25,042 | $808K | 10/7/2025 |
| VIKING GLOBAL INVESTORS LP | ▼ Sell | Open Market | 308,643 | $10.0M | 10/7/2025 |
| Jon Faiz Kayyem | ▼ Sell | Gift | 90,000 | $0 | 3/27/2025 |
| Jon Faiz Kayyem | ▼ Sell | Gift | 500,000 | $0 | 12/16/2024 |
| Jon Faiz Kayyem | ▼ Sell | Gift | 250,000 | $0 | 12/16/2024 |
| Jon Faiz Kayyem | ▼ Sell | Gift | 250,000 | $0 | 12/16/2024 |
| Jon Faiz Kayyem | ▼ Sell | Gift | 52,000 | $0 | 12/6/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 18,750 | $266K | 11/20/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 18,750 | $266K | 11/20/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 34,843 | $496K | 11/19/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 34,843 | $496K | 11/19/2024 |
| Kristiina Vuori, MD | ▲ Buy | Open Market | 6,667 | $100K | 10/3/2024 |
| Mark Lappe | ▲ Buy | Open Market | 13,037 | $223K | 9/16/2024 |
| Mark Lappe | ▲ Buy | Open Market | 26,963 | $406K | 9/12/2024 |
| Kristiina Vuori, MD | ▲ Buy | Open Market | 6,457 | $97K | 9/11/2024 |
| Kristiina Vuori, MD | ▲ Buy | Open Market | 179 | $3K | 9/10/2024 |
| Mark Lappe | ▲ Buy | Open Market | 8,500 | $129K | 9/10/2024 |
| Mark Lappe | ▲ Buy | Open Market | 9,500 | $144K | 9/9/2024 |
| Mark Lappe | ▲ Buy | Open Market | 26,000 | $398K | 9/6/2024 |
| Mark Lappe | ▲ Buy | Open Market | 15,288 | $239K | 9/3/2024 |
| Mark Lappe | ▲ Buy | Open Market | 4,712 | $77K | 9/3/2024 |
| Mark Lappe | ▲ Buy | Open Market | 10,000 | $140K | 8/30/2024 |
| Mark Lappe | ▲ Buy | Open Market | 10,000 | $140K | 8/29/2024 |
| Kristiina Vuori, MD | ▲ Buy | Open Market | 7,140 | $100K | 8/29/2024 |
| Kimberly Manhard | ▲ Buy | Open Market | 10,000 | $140K | 8/28/2024 |
| Douglas Forsyth | ▲ Buy | Open Market | 59,812 | $842K | 8/23/2024 |
| Douglas Forsyth | ▲ Buy | Open Market | 15,188 | $196K | 8/22/2024 |
| Mark Lappe | ▲ Buy | Open Market | 12,945 | $167K | 8/21/2024 |
| Mark Lappe | ▲ Buy | Open Market | 27,055 | $351K | 8/20/2024 |
| Jon Faiz Kayyem | ▼ Sell | Gift | 89,050 | $0 | 6/24/2024 |
| Jon Faiz Kayyem | ▼ Sell | Gift | 10,000 | $0 | 6/24/2024 |
| Jon Faiz Kayyem | ▼ Sell | Gift | 10,000 | $0 | 6/24/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 49,284 | $849K | 6/5/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 8,265 | $148K | 6/5/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 65,337 | $1.1M | 6/4/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 23,726 | $433K | 6/4/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 46,792 | $777K | 6/3/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 80,738 | $1.4M | 6/3/2024 |
| Jon Faiz Kayyem | ▲ Buy | Open Market | 70,193 | $1.1M | 5/31/2024 |
| Jon Faiz Kayyem | ▲ Buy | Grant | 806,075 | — | 5/29/2024 |
| Jon Faiz Kayyem | ▲ Buy | Grant | 6,250 | — | 5/29/2024 |
| Jon Faiz Kayyem | ▲ Buy | Grant | 6,250 | — | 5/29/2024 |
| Douglas Forsyth | ▲ Buy | Grant | 149,564 | — | 5/29/2024 |
| Brendan P. Eckelman | ▲ Buy | Grant | 433,888 | — | 5/29/2024 |
| Brendan P. Eckelman | ▲ Buy | Grant | 40,000 | — | 5/29/2024 |
| Inhibrx, Inc. | ▼ Sell | Other | 13,316,140 | — | 5/29/2024 |
| Mark Lappe | ▲ Buy | Grant | 621,548 | — | 5/29/2024 |
| Mark Lappe | ▲ Buy | Grant | 125,000 | — | 5/29/2024 |
| Mark Lappe | ▲ Buy | Grant | 14,865 | — | 5/29/2024 |
| Brendan P. Eckelman | ▲ Buy | Grant | 40,000 | — | 5/29/2024 |